2022
DOI: 10.3892/ol.2022.13506
|View full text |Cite
|
Sign up to set email alerts
|

Study on the method to avoid infusion‑site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells

Abstract: The combination of intravenous Proemend ® containing fosaprepitant meglumine, a prodrug for fosaprepitant (FAP), and Tween 80 and chemotherapy with anthracyclines, such as epirubicin (EPI), can cause infusion-site adverse events in clinical practice. In immortalized human umbilical vein endothelial (HUEhT-1) cells, the cytotoxic effects of FAP, EPI, diluted Proemend with culture medium and Tween 80 alone, and a combination of FAP and EPI, were evaluated using the WST-1 cell viability assay. FAP, EPI and dilute… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 26 publications
(33 reference statements)
0
1
0
Order By: Relevance
“…The human vascular endothelial HUEhT‐1 cells, which were established from human umbilical vein endothelial cell line by electroporation of pIRES‐hTERT‐hygr, 20 , 21 , 22 and mouse vascular endothelial UV2 cells 23 , 24 , 25 were purchased from the Japanese Collection of Research Bioresources Cell Bank (Ibaraki, Japan) and RIKEN BioResorce Research Center, respectively. The HUEhT‐1 cells were grown in MCDB131 medium (Gibco) containing 10% (v/v) foetal calf serum (FCS), 10 mM L‐glutamine, 5 μg/mL heparin, 30 mg/L endothelial cell growth supplement (Corning, Corning, NY), 100 units/mL penicillin G (FUJIFILM Wako) and 100 μg/mL streptomycin (FUJIFILM Wako).…”
Section: Methodsmentioning
confidence: 99%
“…The human vascular endothelial HUEhT‐1 cells, which were established from human umbilical vein endothelial cell line by electroporation of pIRES‐hTERT‐hygr, 20 , 21 , 22 and mouse vascular endothelial UV2 cells 23 , 24 , 25 were purchased from the Japanese Collection of Research Bioresources Cell Bank (Ibaraki, Japan) and RIKEN BioResorce Research Center, respectively. The HUEhT‐1 cells were grown in MCDB131 medium (Gibco) containing 10% (v/v) foetal calf serum (FCS), 10 mM L‐glutamine, 5 μg/mL heparin, 30 mg/L endothelial cell growth supplement (Corning, Corning, NY), 100 units/mL penicillin G (FUJIFILM Wako) and 100 μg/mL streptomycin (FUJIFILM Wako).…”
Section: Methodsmentioning
confidence: 99%